Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5394-18-3

Post Buying Request

5394-18-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5394-18-3 Usage

Description

N-(4-Bromobutyl)phthalimide is a white crystalline powder that serves as a versatile reagent in the field of organic synthesis and pharmaceutical production. It is known for its ability to react with 1-phenyl-piperazine, leading to the formation of N-[4-(4-phenyl-piperazin-1-yl)-butyl]-phthalimide, which is a significant intermediate in the synthesis of various compounds.

Uses

Used in Organic Synthesis:
N-(4-Bromobutyl)phthalimide is used as a synthesis reagent for the creation of B-cyclodextrin derivatives. Its unique chemical properties allow it to be a valuable component in the development of these complex molecules, which have a wide range of applications in various industries.
Used in Pharmaceutical Production:
In the pharmaceutical industry, N-(4-Bromobutyl)phthalimide is utilized as a key intermediate in the synthesis of various drugs. Its ability to react with different compounds makes it a crucial component in the development of new medications, contributing to the advancement of pharmaceutical research and drug discovery.
Used in Chemical Research:
N-(4-Bromobutyl)phthalimide is also employed in chemical research as a starting material for the synthesis of a variety of complex organic compounds. Its unique properties and reactivity make it an essential tool for chemists working on the development of new chemical entities and materials.

Check Digit Verification of cas no

The CAS Registry Mumber 5394-18-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,3,9 and 4 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 5394-18:
(6*5)+(5*3)+(4*9)+(3*4)+(2*1)+(1*8)=103
103 % 10 = 3
So 5394-18-3 is a valid CAS Registry Number.
InChI:InChI=1/C12H12BrNO2/c13-7-3-4-8-14-11(15)9-5-1-2-6-10(9)12(14)16/h1-2,5-6H,3-4,7-8H2

5394-18-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A14517)  N-(4-Bromobutyl)phthalimide, 98%   

  • 5394-18-3

  • 5g

  • 420.0CNY

  • Detail
  • Alfa Aesar

  • (A14517)  N-(4-Bromobutyl)phthalimide, 98%   

  • 5394-18-3

  • 25g

  • 1910.0CNY

  • Detail
  • Alfa Aesar

  • (A14517)  N-(4-Bromobutyl)phthalimide, 98%   

  • 5394-18-3

  • 100g

  • 3943.0CNY

  • Detail
  • Aldrich

  • (100919)  N-(4-Bromobutyl)phthalimide  98%

  • 5394-18-3

  • 100919-10G

  • 1,095.12CNY

  • Detail

5394-18-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(4-Bromobutyl)phthalimide

1.2 Other means of identification

Product number -
Other names 2-(4-bromobutyl)-1H-isoindole-1,3(2H)-dione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5394-18-3 SDS

5394-18-3Relevant articles and documents

Synthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitors

Jarończyk, Ma?gorzata,Wo?osewicz, Karol,Gabrielsen, Mari,Nowak, Gabriel,Kufareva, Irina,Mazurek, Aleksander P.,Ravna, Aina W.,Abagyan, Ruben,Bojarski, Andrzej J.,Sylte, Ingebrigt,Chilmonczyk, Zdzis?aw

, p. 200 - 210 (2012)

It is well known that 6-nitroquipazine exhibits about 150-fold higher affinity for the serotonin transporter (SERT) than quipazine and recently we showed quipazine buspirone analogues with high to moderate SERT affinity. Now we have designed and synthesized several 6-nitroquipazine buspirone derivatives. Unexpectedly, their SERT binding affinities were moderate, and much lower than that of the previously studied quipazine buspirone analogues. To explain these findings, docking studies of both groups of compounds into two different homology models of human SERT was performed using a flexible target-ligand docking approach (4D docking). The crystal structures of leucine transporter from Aquifex aeolicus in complex with leucine and with tryptophan were used as templates for the SERT models in closed and outward-facing conformations, respectively. We found that the latter conformation represents the most reliable model for binding of buspirone analogues. Docking into that model showed that the nitrated compounds acquire a rod like shape in the binding pocket with polar groups (nitro- and imido-) at the ends of the rod. 6-Nitro substituents gave steric clashes with amino acids located at the extracellular loop 4, which may explain their lower affinity than corresponding quipazine buspirone analogues. The results from the present study may suggest chemical design strategies to improve the SERT modulators.

A Model for Nicotinamide-Tryptophane Charge-Transfer Interactions: the Complexation of Nicotinamide-Ammonium Salts by a Macrocyclic Receptor Molecule Bearing Tryptophane Side Chains

Behr, Jean-Paul,Lehn, Jean-Marie

, p. 2112 - 2118 (1980)

The complexation of primary ammonium salt substrates by macrocyclic polyether receptor molecules provides a general method for studying the nature and stereochemistry of intermolecular interactions.The substrates and receptors are fitted with one of the interacting units and the resulting effects in the complex are analyzed.The method is used to study the biologically important indole-pyridinium donor-acceptor interaction.The complexes between macrocycles, bearing an indole group in side chains, and pyridinium-ammonium salts display a characteristic charge-transfer band.The absorption coefficients and stability constants have been determined.Competition experiments also provide a new method for measuring the stability constants of macrocycle-ammonium complexes in organic solvents.

Synthesis of diosgenyl quaternary ammonium derivatives and their antitumor activity

Xia, Xi,Chen, Yu,Wang, Lin,Yang, Zhi-Gang,Ma, Xiao-Dong,Zhao, Zhi-Gang,Yang, Hong-Jun

, (2021)

Giosgenin is a naturally steroidal saponin exhibiting a variety of biological activities including antitumor ones. A series of novel diosgenyl quaternary ammonium derivatives were designed and synthesized to develop potential anti-tumor agents in our research. All novel derivatives were characterized by 1H NMR, 13C NMR and HR-MS, and evaluated for their in vitro anti-proliferative activities using MTT assay. The human cancer cell lines were A549 (Human lung cancer cell), H1975 (Human lung adenocarcinoma cell), A431 (Human skin squamous cell carcinoma), HCT-116 (Human colorectal adenocarcinoma cell), Aspc-1 (Human metastatic pancreatic cancer cell), Ramos (Human B lymphoma cell), HBE (Human bronchial epithelioid cell) and LO2 (Human normal hepatocyte).

Synthesis of New 1,2,3-Triazolo-naphthalimide/phthalimide Conjugates via ‘Click’ Reaction: DNA intercalation and cytotoxic studies

Shankaraiah, Nagula,Kumar, Niggula P.,Tokala, Ramya,Gayatri, Bulusu S.,Talla, Venu,Santos, Leonardo S.

, p. 454 - 461 (2019)

Cancer is a complex disease which involves abnormalities of multiple cellular pathways. Current chemotherapeutic drugs are mainly designed to target the DNA and cell division. Therefore, in the present study, we have synthesized a new series of 1,2,3-triazolo-naphthalimide/phthalimide conjugates and evaluated their in vitro cytotoxicity against selected human cancer cells. Among the tested compounds, one of them displayed notable cytotoxic activity against A549 lung cancer cells with an IC50 (half maximal inhibitory concentration) value of 7.6 ± 0.78 μM. To determine the effect of this compound on cell viability, acridine orange/ethidium bromide (AO/EB) and 4’,6-diamidino-2-phenylindole (DAPI) staining studies were performed. These apoptotic features were clearly indicating that the compound inhibited cell proliferation by apoptosis. Further, relative viscosity measurements and molecular docking studies with the most three active compounds indicated that these new compounds bind to DNA by intercalation.

Antioxidant activity of two edible isothiocyanates: Sulforaphane and erucin is due to their thermal decomposition to sulfenic acids and methylsulfinyl radicals

Cedrowski, Jakub,D?browa, Kajetan,Przybylski, Pawe?,Krogul-Sobczak, Agnieszka,Litwinienko, Grzegorz

, (2021/03/30)

Sulforaphane (SFN) and erucin (ERN) are isothiocyanates (ITCs) bearing, respectively, methylsulfinyl and methylsulfanyl groups. Their chemopreventive and anticancer activity is attributed to ability to modulate cellular redox status due to induction of Phase 2 cytoprotective enzymes (indirect antioxidant action) but many attempts to connect the bioactivity of ITCs with their radical trapping activity failed. Both ITCs are evolved from their glucosinolates during food processing of Cruciferous vegetables, therefore, we studied antioxidant behaviour of SFN/ERN at elevated temperature in two lipid systems. Neither ERN nor SFN inhibit the oxidation of bulk linolenic acid (below 100 °C) but both ITCs increase oxidative stability of soy lecithin (above 150 °C). On the basis of GC-MS analysis we verified our preliminary hypothesis (Antioxidants 2020, 9, 1090) about participation of sulfenic acids and methylsulfinyl radicals as radical trapping agents responsible for the antioxidant effect of edible ITCs during thermal oxidation of lipids at elevated temperatures (above 140 °C).

Design, synthesis and preliminary bioactivity evaluation of bitopic benzopyranomorpholine analogues as selective dopamine D3 receptor ligands as anti-drug addiction therapeutic agents

Cai, Jin,Chen, Xixi,Huang, Mingqi,Ji, Min,Wang, Yuhong

, (2021/08/09)

Three series of bitopic benzopyranomorpholine analogues were designed, synthesized, and evaluated as a novel class of selective ligands for the dopamine D3 receptor. Binding affinities of target compounds were determined using the method of radioligand binding assay. Most compounds demonstrated considerable binding affinities and selectivity for D3 receptor. Besides, the compounds were screened for their ability to alleviate withdrawal symptoms of opioid addiction in animal behavioral models. The results showed that compound 20h displayed nanomolar affinity for the D3R, and exhibited anti-drug addiction efficacy in the animal model of of naloxone-induced withdrawal symptoms in morphine-dependent mice.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5394-18-3